Smith M D, Hong B A, Robson A M
Am J Med. 1985 Aug;79(2):160-6. doi: 10.1016/0002-9343(85)90004-x.
To evaluate the variability in the diagnosis of depression in patients receiving maintenance therapy for end-stage renal disease, a study of 60 randomly selected patients was conducted. Three representative depression assessment methods were employed concurrently in the evaluation of each patient: (1) a structured psychiatric interview based on the diagnostic criteria of the American Psychiatric Association (DSM-III); (2) the Beck Depression Inventory; and (3) the Multiple Affect Adjective Check List. Among the 60 patients, 47 percent were classified as depressed by the Beck Depression Inventory, whereas 17 percent and 5 percent were determined to be depressed according to the Multiple Affect Adjective Check List and DSM-III criteria, respectively. The data demonstrated these differences to be dependent on the overlap between the symptoms of uremia and depression, as well as on the duration of those symptoms. This study also suggests that death wish, suicidal intention, and other psychologic symptoms should receive particular attention in the clinical assessment of depression in patients with end-stage renal disease.
为评估接受终末期肾病维持治疗患者抑郁症诊断的变异性,对60名随机选取的患者进行了一项研究。在对每位患者的评估中同时采用了三种具有代表性的抑郁症评估方法:(1)基于美国精神病学协会诊断标准(DSM-III)的结构化精神科访谈;(2)贝克抑郁量表;以及(3)多项情感形容词检查表。在这60名患者中,47%被贝克抑郁量表判定为抑郁,而根据多项情感形容词检查表和DSM-III标准判定为抑郁的分别为17%和5%。数据表明这些差异取决于尿毒症症状与抑郁症症状的重叠情况以及这些症状的持续时间。这项研究还表明,在终末期肾病患者抑郁症的临床评估中,死亡意愿、自杀意图及其他心理症状应受到特别关注。